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Abstract. Stroke is not only a major cause of death, but also a leading cause of disability 
worldwide. Metabolic syndrome is one of the predictor of stroke since it has been linked to 
the development of atherosclerosis that will lead to cerebrovascular event. Albuminuria is 
known to be an indicator of endothelial dysfunction that is a major cause of cerebrovascular 
disease. In this study, 50 subjects of acute ischemic stroke consist of 25 subjects of acute 
ischemic stroke with metabolic syndrome and 25 subjects of acute ischemic stroke without 
metabolic syndrome. The ischemic stroke with metabolic syndrome population is 
significantly associated with increased risk of albuminuria 16 times higher than the 
ischemic stroke without metabolic syndrome (OR = 16, IK95% 1.855 – 137.97, 
p=0.002).Subjects of ischemic stroke with metabolic syndrome is significantly associated 
with increased risk of albuminuria. 
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1. Introduction 
Stroke is an episode of neurological acute dysfunction caused by ischemic or bleeding 
for 24 hours or death. There is no sufficient evidence to be classified. Stroke ischemic is 
an episode of neurological dysfunction caused by cerebral focal infarction, spinal and 
retinal infarcts. Several risk factors related to stroke ischemic are divided into 2 
categories: factor modified (such as hypertension and diabetes mellitus) and factor non-
modified (such as age and sex) (Sacco et al, 2013). 
Albuminuria is the sign of general vascular disease and permeability increased of blood 
vessels that effect the large penetration of atherogenic lipo-protein particles to artery 
wall. Microalbuminuria is the sign of endothelia blood vessel damaging. Thus, the 
dysfunction of endothel in the brain connected with permeabilities membrane increased 
can be done by seeing the existence of permeability membrane increased the renal using 
the microalbuminiura examination (Mykkanen dkk, 1997) 
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The increasing of urinary albumin levels are significant determinant of the occurrence 
CIMT from cardiovascular risk factors in type 2 DM patients. This significant 
relationship may refer to the pathophysiological relationship of atherosclerosis (Yuyun 
et al, 2004). 
2. Methodology 
2.1 Place and Time 
The study was conducted at Department of Neurology FK - USU / RSUP H. Adam 
Malik Medan from March 2, 2016 to 10 October 2016. 
2.2 Subject Study 
       The subject of study were taken from the population patient treated in the 
neurological inpatient ward, the determination of the study subjects was conducted 
according to the method of taking sample of consecutive sampling.  This study used 
some instruments such as Computed Tomography Scan (CT Scan) head: CT Scan which 
used is X-Ray CT System, Hitachi brand W 450 series, then for  the examination of 
profile lipid was measured by using Cobas 6000, the measurement of Blood glucose by 
using  Cobas 6000, the measurement of Blood pressure with spigmomanometer, the 
Measurement waist circumference with a tape meter, and also the last  measurement of 
Urine albumin was performed by using a dipstick with the URS-4SG brand. 
 
1. All ischemic acute stroke patients who were treated in neurological inpatient 
room of RSUP. H. Adam Malik Medan have been performed with anamnesis, 
examination of neurology and examination  CT scan head, were taken 
consecutively and fulfilling the criteria inclusion and exclusion, venous blood 
were taken ± 5ml after fasted for 8 hours to be examined triglyceride, HDL and 
fasting blood glucose. Triglycerides are group of water-soluble glycerol plasma 
esters. Divided into optimal levels (<150 mg / dl), borderline (150-199 mg / dl), 
high (200-499 mg / dl) and very high (> 500 mg / dL) (Soegnado and 
Purnamasari, 2009). High dencity lipoprotein (HDL) is a lipoprotein produced 
by the liver and intestine and contains phospholipids and apolipoprotein 
(Fischbach, 2004). Divided into high levels (≥60 mg / dl), low (<40 mg / dl) 
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(Soegnado and Purnamasari, 2009). When urine were performed by using 
specimen urine random or when urine were 5 ml and examined using dipstick 
for the value of urine albumin  
The waist circumference is measured at the midpoint between the lower margin from 
rib and the part of iliac tops using the tap meter. The measurement of blood pressure 
performed with using standard spigmomanometer. Patient should be calm and 
performed after a 5-minute break. 
 
4. Result and Discussion 
The result of analy sis used Chi Square test showed that there was significant 
relationship between albuminuria with metabolic syndrome (p <0.001). The result OR 
value which means the subject with metabolic syndrome will be at risk if having 
albuminuria 16 times higher than subjects without metabolic syndrome.  
Table I The Criteria for Metabolic Syndrome based on ATP III (2001) 
 Criteria clinical 
Weight LP ≥102 cm male or ≥ 88 cm female 
Trigliserida ≥ 150 mg/dl  
HDL < 40 mg/dl male atau <50 mg/dl female 
Blood Pressure ≥ 130/85 mmHg 
Fasting Glucose ≥ 110 ,mg/dl (include patient DM) 
Dikutip dari : Soegnado, S.,dan Purnamasari, D. 2009. Sindrom metabolik. Dalam: 
Sudoyo, A., Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S. Buku ajar ilmu penyakit 
dalam. Interna publishing. Jakarta. 1865-1879 
 The correlation value was obtained 0.435 means there was medium correlation between 
albuminuria with metabolic syndrome. 
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Table II . Demographic characteristics of research subjects 
Characteristic Demographic 
Syndrom  
Metabolic(+) 
(n=25) 
Syndrom  
Metabolic (-) 
(n =25) 
Gender, n (%)   
 Male 17 (68) 14 (56) 
   Female 8 (32) 11 (44) 
Age, Mean (SB), Year   
   ≥51 years old 19 (76) 19 (76) 
   <51 years olf 6 (24) 6 (24) 
Hypertension, n (%)   
   Yes 24 (96) 19 (76) 
   No 1 (4) 6 (24) 
DM, n (%)   
   Yes 21 (84) 10 (40) 
   No 4 (16) 15 (60) 
Albuminuria, n(%) 
    No 
     Light 
     Average 
     Severe 
 
1 (2) 
10 (20) 
8 (16) 
6 (12) 
 
10 (20) 
15 (30) 
0 (0) 
0 (0) 
 
Total of 21 people (84%) subjects with metabolic syndrome had a history of DM and 
only 10 people (40%) in the non metabolic syndrome group. In the SI group with SM, 1 
person (2%) no experience albuminuria, 10 people (20%) light experienced 
albuminuria, 8 people (16%) average experienced albuminuria and 6 people (12%) 
severe experienced albuminuria while in the SI group without SM, 10 people (20%) no 
experience albuminuria and 15 people (30%) light experienced albuminuria. 
 
Table III The risk of albuminuria to the ischemic acute patient with metabolic 
syndrome  
 
 
 
 
 
 
 
aFisher’s Exact bSpearman 
 
From 25 subjects of acute ischemic stroke with metabolic syndrome was obtained 24 
subjects (96%) with albuminuria. Meanwhile, from 25 subjects with no metabolic 
syndrome was obtained 15 subjects (60%) with albuminiura.  
Syndrome 
Metabolic 
Albuminiura 
p OR 
(95% 
IK) 
R 
Yes No 
Yes 24 
(96) 
1  
(4) 
0.002a 16a 1.855-
137.97 
0.435b 
No 15 
(60) 
10 
(40) 
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The results of the analysis using Chi Square test showed there was a significant 
relationship between albuminuria with metabolic syndrome (p <0.001). The resulting 
OR value is 16 which means subjects with metabolic syndrome will be at risk of having 
albuminuria 16 times greater than subjects without the metabolic syndrome. The 
correlation value obtained is 0.435 meaning that there is a moderate correlation between 
albuminuria with metabolic syndrome. 
 
5. Conclusion 
 
Based on the results of data analysis in this study, it could be concluded that ischemic 
acute stroke patients with metabolic syndrome had the 16 times bigger risk to have 
albuminuria compared to patient with ischemic acute without metabolic syndrome (OR 
= 16,  IK95% 1.855-137.97) 
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